21.8 C
New York
Wednesday, June 10, 2026

Tag: process

newssourceFORcompanyinformationcontent1marketreleases

CLINICIANS AT THREE OF WASHINGTON’S LARGEST HEALTHCARE SYSTEMS FILE TO UNIONIZE, CITING PATIENT CARE CONCERNS

SEATTLE, June 9, 2026 /PRNewswire/ -- Two hundred and fifty nurse practitioners and physician assistants working across multiple clinic locations at Fred Hutchinson Cancer...

Asante partners with Western University of Health Sciences to launch core rotation sites for medical students in southern Oregon

LEBANON, Ore., June 9, 2026 /PRNewswire/ -- In an effort to continue building the health care workforce pipeline in southern Oregon, Asante announced today a...

FDA approves Lilly’s EBGLYSS® (lebrikizumab-lbkz) for one maintenance dose every eight weeks in patients with moderate-to-severe atopic dermatitis

EBGLYSS is now the only approved option that offers as few as six maintenance injections per year with no required topicals from the startINDIANAPOLIS,...

/C O R R E C T I O N — Ghirardelli/

In the news release, Ghirardelli Introduces the Effortless Enjoyment of a Homemade Cookie with New Premium Refrigerated Cookie Dough, issued 09-Jun-2026 by Ghirardelli over...

HyOrc Corporation Retains Stonegate Capital Partners to Lead Investor Outreach and Support Nasdaq Uplisting Strategy

HyOrc Corporation Retains Stonegate Capital Partners to Lead Investor Outreach and Support Nasdaq Uplisting Strategy

Cellectis Receives FDA RMAT Designation for lasme-cel, the First Allogeneic CAR-T Therapy in a Pivotal Trial for Patients with r/r B-ALL

NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop life-saving cell and gene therapies, today announced that the U.S. Food and Drug Administration (FDA) granted Regenerative Medicine Advanced Therapy (RMAT) designation to lasmecabtagene timgedleucel (lasme-cel), its CD22-targeting allogeneic CAR-T cell therapy product candidate, for the treatment of patients with relapsed or refractory B-cell acute lymphoblastic leukemia (r/r B-ALL).

Charlotte Volsch, Apple Valley, California Broker, Named Among Real Trends 2026 Best Real Estate Agents in the United States by RealTrends Verified | #1826...

Inland Empire and High Desert Probate and Trust Real Estate Specialist Ranks in the Top 1% of California Realtors 
Inland Empire and High Desert Probate and Trust Real Estate Specialist Ranks in the Top 1% of California Realtors

TraceLink Wins ISM Supply Chain Trailblazer Award for OPUS, Advancing Real-Time Multienterprise Supply Chain Execution

Recognition highlights the impact of OPUS, the Orchestration Platform for Universal Solutions, in helping life sciences and healthcare companies digitalize multienterprise transactions and processes...

ARRAS MINERALS DRILLS 935.9M GRADING 0.71% CUEQ FROM SURFACE INCLUDING 214.9M GRADING 1.42% CUEQ STARTING AT 162.1M DEPTH FROM THE BEREZSKI NORTH PORPHYRY TARGET,...

TSX-V: ARK / OTCQB: ARRKFVANCOUVER, BC, June 9, 2026 /CNW/ - Arras Minerals Corp. (TSXV: ARK) (OTCQB: ARRKF) ("Arras" or "Arras Minerals" or "the Company")...

Claimio Announces Rebrand Following USC & Techstars Accelerator, Bringing New Technology to the Unclaimed Property Market

Following its selection as one of eight companies in the highly competitive USC & Techstars Spring 2026 Accelerator cohort, Claimio enters its next phase of growth with expanding traction, new technology, and a broader vision for modernizing unclaimed property recovery. 
Following its selection as one of eight companies in the highly competitive USC & Techstars Spring 2026 Accelerator cohort, Claimio enters its next phase of growth with expanding traction, new technology, and a broader vision for modernizing unclaimed property recovery.

Dr. Yorell Manon-Matos Launches 2027 Healthcare Scholarship Applications

SIOUX FALLS, S.D., June 09, 2026 (GLOBE NEWSWIRE) -- The Dr. Yorell Manon-Matos Scholarship for Healthcare Students has officially opened its application cycle for 2027, aimed at empowering the next generation of medical innovators and clinical leaders.

OMI Launches Motor Production at New Puebla Facility

PUEBLA, Mexico, June 9, 2026 /PRNewswire/ -- OMI has begun motor production at its new OMI Puebla facility, a move that expands the company's...

ProLogium and OPmobility Sign MoU to develop next generation Solid-State Battery Modules for Mobility

From Cells to System Integration: Launching Joint Evaluation of Solid-State Battery Modules for EV Applications 
From Cells to System Integration: Launching Joint Evaluation of Solid-State Battery Modules for EV Applications

Arctic Air Brand Under Investigation: Evaluating the Arctic Air Ice Jet X3 & Air Cooler Product Details Including Claims & Feedback In 2026

Fairfield, NJ, June 09, 2026 (GLOBE NEWSWIRE) -- A 2026 consumer overview examining Arctic Air Ice Jet X3 cooling technology claims, Arctic Air cooler cooling efficiency, return policy requirements and what product information publicly available across the Arctic Air portfolio.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsProcess

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers